🇺🇸 FDA
Patent

US 12338459

DNA-chimeric antigen receptor T cells for immunotherapy

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12338459 (DNA-chimeric antigen receptor T cells for immunotherapy) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2239/49